Gist GL, Burg JR. Trichloroethylene--a review of the literature from a health effects perspective. Toxicol Ind Health 1995;11:253-307.
Burg JR, Gist GL, Allred SA, Radtke TM, Pallos LL, Cusack CD. National Exposure Registry--Morbidity analyses of noncancer outcomes from the Trichloroethylene Subregistry baseline data. Int J Occup Med Toxicol 1995;4(2):237-57.
Gist GL, Burg JR, Allred SA. Implementation of the Trichloroethylene Subregistry of the National Exposure Registry. In Proceedings of the International Congress on the Health Effects of Hazardous Waste. JS Andrews, H Frumkin, BL Johnson, MA Mehlman, C Xintaras, and JA Bucsela (eds.). U.S. Department of Health and Human Services, Public Health Service, Atlanta, Georgia, 1994;901-4.
Je Anne R. Burg,Sarah L. Allred, James H. Sapp, II. The Potential for Bias Due to Attrition in the National Exposure Registry: An Examination of Reasons for Nonresponse, Nonrespondent Characteristics, and the Response Rate Toxicology and Industrial Health, VOL. 13, Nov 1, 1997.
GENERAL JOURNAL ARTICLES
Gist GL, Burg JR. Methodology for selecting substances for the National Exposure Registry. J Exposure Analysis and Environmental Epidemiology 1995;5:197-208.
Gist GL, Burg JR, Radtke TM. The site selection process for the National Exposure Registry. J Environ Health 1994;56(6):7-12.
Heitgerd JL, Burg JR, Strickland, HG. A geographic information systems approach to estimating and assessing National Priorities List site demographics: racial and hispanic origin composition. Int J Occup Med Toxicol 1995;4(3):343-63.
Berry M, Bove F. Birth weight reduction associated with residence near a hazardous waste landfill. Environ Health Perspect 1997;105:856-61.
Leviton LC, Marsh GM, Talbott E, Pavlock D, Callahan C. Drake Chemical Workers' Health Registry: coping with community tension over toxic exposures. Am J Public Health 1991;81(6):689-93.
Fingerhut MA, Halperin WE, Marlow DA, Piacitelli LA, Honchar PA, Sweeney MH, Greife AL, Dill PA, Steenland K, Suruda AJ. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. NEJM 1991;324(4):212-8.
Marsh GM, Callahan C, Pavlock D, Leviton LC, Talbott EO, Hemstreet G. A protocol for bladder cancer screening and medical surveillance among high-risk groups: the Drake Health Registry experience. J Occup Med 1990;32(9):881-6.
Patterson DG, Fingerhut MA, Roberts DW, Needham LL, Sweeney MH, Marlow DA, Andrews JS, Halperin WE. Levels of polychlorinated dibenzo-p-dioxins and dibenzofurans in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Ind Med 1989;16(2):135-46.
Andrews JS, Garrett WA, Patterson DG, Needham LL, Roberts DW, Bagby JR, Anderson JE, Hoffman RE, Schramm W. 2,3,7,8-Tetrachlorodibenzo-p-dioxin levels in adipose tissue of persons with no known exposure and in exposed persons. Chemosphere 1989;18:499-506.
Stehr PA, Stein G, Falk H, Sampson E, Smith SJ, Steinberg K, Webb K, Ayers S, Schramm W, Donnell HD, Gedney WB. A pilot epidemiologic study of possible health effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin contaminations in Missouri. Arch Environ Health 1986;41(1):16-22.
Lapeza CR, Patterson DG, Liddle JA. Automated apparatus for the extraction and enrichment of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human adipose tissue. Anal Chem 1986;58(4):713-6.
Calvert GM, Sweeney MH, Deddens J, Wall DK. Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 1999;6(4):270-6.
Halperin W, Vogt R, Sweeney MH, Shopp G, Fingerhut M, Petersen M. Immunological markers among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 1998;55(11):742-9.
Calvert GM, Wall DK, Sweeney MH, Fingerhut MA. Evaluation of cardiovascular outcomes among U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ Health Perspect 1998;106 Suppl 2:635-43.
Sweeney MH, Calvert GM, Egeland GA, Fingerhut MA, Halperin WE, Piacitelli LA. Review and update of the results of the NIOSH medical study of workers exposed to chemicals contaminated with 2,3,7,8-tetrachlorodibenzodioxin. Terat Carcin Mutagen 17(4-5):241-7, 1997-98.
Calvert GM, Wille KK, Sweeney H, Fingerhut MA, Halperin WE. Evaluation of serum lipid concentrations among U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Environ Health 1996;51(2):100-7.
Halperin W, Kalow W, Sweeney MH, Tang BK, Fingerhut M, Timpkins B, Wille K. Induction of P-450 in workers exposed to dioxin. Occup Environ Med 1995;52(2):86-91.
Calvert GM, Sweeney MH, Fingerhut MA, Hornung RW, Halperin WE. Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Ind Med 1994;25(4):559-71.
Marsh GM, Leviton LC, Talbott EO, Callahan C, Pavlock D, Hemstreet G, Logue JN, Fox J, Schulte P. Drake Chemical Workers' Health Registry Study: I. Notification and medical surveillance of a group of workers at high risk of developing bladder cancer. Am J Ind Med 1991;19(3):291-301.
Leviton LC, Chen HT, Marsh GM, Talbott EO. Evaluation issues in the Drake Chemical Workers Notification and Health Registry Study. Am J Ind Med 1993;23(1):197-204.
>Calvert GM, Hornung RW, Sweeney MH, Fingerhut MA, Halperin WE. Hepatic and gastrointestinal effects in an occupational cohort exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. JAMA 1992;267(16):2209-14.
Calvert GM, Sweeney MH, Morris JA, Fingerhut MA, Hornung RW, Halperin WE. Evaluation of chronic bronchitis, chronic obstructive pulmonary disease, and ventilatory function among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am Rev Resp Dis 1991;144(6):1302-6.
Stehr-Green PA, Naylor PH, Hoffman RE. Diminished thymosin alpha-1 levels in persons exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Toxicol Environ Health 1989;28:285-95.